Workshops for North Thames cancer teams focused on roles and responsibilities within the cancer team relating to the diagnostic pathway.
About this event
Lynch syndrome (LS) is an inherited condition caused by pathogenic variants in DNA genes which result in an increased risk of colorectal, endometrial, and other cancers.
- Increases risk of developing bowel cancer to up to 80%
- Previously called hereditary non-polyposis colorectal cancer (HNPCC).
LS affects approximately 1 in 300-1 in 400 people, with 200,000-300,000 people likely to have this condition in the UK. It is estimated that only 5% of people with LS have been diagnosed with this condition.
These regional workshops will outline the responsibilities of local cancer MDT members in the Lynch syndrome testing pathway.
The virtual workshops will be held on:
- Monday 21st March: 1-2 pm
- Tuesday 26th April: 1-2 pm
The workshops will be led by:
- Kevin Monahan, Consultant Gastroenterologist at St Mark’s Hospital and Co-Chair of the national NHS GMS Lynch Syndrome Oversight Group
- Laura Monje-Garcia, Nurse Practitioner & Lynch Syndrome Project Lead Nurse at The St Mark’s Centre for Familial Intestinal Cancer
All cancer MDT members are welcome.